Prevalence of cytomegalovirus infection in steroid-refractory Crohn's disease

Inflammatory Bowel Diseases

Volumn 18, Issue 7, 2012, Pages

  Roblin, Xavier ^a,b   Pillet, Sylvie ^a,b   Berthelot, Philippe ^a   Del Tedesco, Emilie ^b   Phelip, Jean Marc ^b   Chambonnière, Marie Laure ^b   Biroulet, Laurent Peyrin ^c   Pozzetto, Bruno ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; VIRUS DNA;

ADULT; COLONOSCOPY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; LETTER; MALE; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SIGMOIDOSCOPY; STEROID THERAPY; ULCERATIVE COLITIS; VIRUS DETECTION; VIRUS LOAD;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE; FEMALE; HUMANS; MALE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; STEROIDS;

EID: 84861341333     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21907     Document Type: Letter

References (16)

1. Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis. 2010;16:1620-1627.
2. Hommes DW, Sterringa G, van Deventer SJ, et al. The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis. 2004;10:245-250. (Pubitemid 38618254)
3. Roblin X, Pillet S, Oussalah A, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immuno-suppressive therapy in ulcerative colitis. Am J Gastroenterol. 2011 [Epub ahead of print].
4. N'guyen Y, Baumard S, Salmon JH, et al. Cytomegalovirus associated hemophagocytic lymphohistiocytosis in patients suffering from Crohn's disease treated by azathioprine: a series of four cases. Inflamm Bowel Dis. 2011;17:E116-118.
5. Le ST, Lee SS, Prideaux L, et al. Primary cytomegalovirus ileitis complicated by massive gastrointestinal haemorrhage in a patient with steroid refractory Crohn's disease. Intern Med J. 2010;40:788-791.
6. Dimitroulia E, Spanakis N, Konstantidiniou AE, et al. Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:879-884. (Pubitemid 44352715)
7. Kuwabara A, Okamoto H, Suda T, et al. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol. 2007; 42:823-829. (Pubitemid 47617460)
8. Pillet S, Bourlet T, Pozzetto B. Comparative evaluation of a commercially available automated system for extraction of viral DNA from whole blood: application to monitoring of Epstein-Barr virus and cytomegalovirus load. J Clin Microbiol. 2009;47:3753-3755.
9. Schanen C, Nasri D, Bourlet T, et al. Enterovirus in arteriosclerosis: a pilot study. J Clin Virol. 2007;39:106-112. (Pubitemid 46777434)
10. Yoshino T, Nakase H, Ueno S, et al. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis. 2007;13:1516-1521.
11. Nakase H, Yoshino T, Honzawa Y, et al. Low prevalence of CMV infection in patients with Crohn's disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection. Dig Dis Sci. 2010;55:1498-1499.
12. Kim JJ, Simpson N, Klipfel N, et al. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci. 2010;55:1059-1065
13. Nakase H, Matsumura K, Yoshino T, et al. Systematic review: cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol. 2008;43:735-740
14. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009;22:76-98.
15. Rahier JF, Ben-Horin S, Chowers Y, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009;3:47-91.
16. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1756-1767.